{
  "docId": "019dd923-5e88-73ef-bd5a-9cdc5d048fe2",
  "docSlug": "03e126adc7ca1480",
  "documentTitle": "20250114 bayer handout jpm 2025",
  "authorId": "JPMorgan",
  "authorName": "Bayer",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 13,
  "pageCount": 18,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "kpi_dashboard",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 20,
  "notes": "The slide uses a dot-plot visualization to represent pipeline progression and lists specific drug programs.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "infographic",
    "process_diagram"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-9cdc5d048fe2/13",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2#slide-13",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Advanced or Completed over 20 Clinical Programs across phases in past 18 months",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-2301-748f-910f-d0dd4963fdf7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.38,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Pipeline progress since June 2023",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca455dd7-5e20-4497-9870-c25fbc60a95a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.7,
        "y": 0.25
      },
      "kind": "list",
      "text": "Phase III additions: Bemdaneprocel, HER2/m EGFR Inh, Kerendia. Phase III completions: Asundexian, Elinzanetant, Nubeqa, Kerendia, Eylea 8mg, Gadoquatrane.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44266c5f-cf4d-4d7c-bedb-60dffb616db3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.08,
        "y": 0.25
      },
      "kind": "list",
      "text": "Phase I additions: VVD Keap1 Act, VVD STAT3 Inh, 225Ac-Pelgifatamab, 225Ac-PSMA-Trillium, SOS1 Inhibitor, DGKalpha Inh, BAY 3389934, BAY 2701250. Phase II additions: AB-1002, AB-1005, Anti-alpha2-AP, sGC activator oral.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6fb7a581-399f-4668-8109-156c4fa1ab1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.08,
        "y": 0.8
      },
      "kind": "metric",
      "text": "Advanced or Completed over 20 Clinical Programs across phases in past 18 months",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "202e1d04-9c79-4e45-b344-6bb4e20189ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.68,
        "y": 0.8
      },
      "kind": "metric",
      "text": "Shifted resources to assets with highest potential",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5372ab39-90e7-432c-bbc5-1286acb03f2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.38,
        "y": 0.8
      },
      "kind": "metric",
      "text": "Focused on 4 Strategic Innovation Areas",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6143d40d-4d09-456c-8c52-931a5a85e00e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.08,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pipeline Replenishment in Full Swing, Driven by New Innovation Model",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e2fea0b-0aaa-4201-8059-a8fb4a007195",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 9,
      "beatId": "f381b448-fcf0-4030-b26e-c9fd2c74d1c9",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The slides showcase the company's market-leading positions and innovation",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}